300 patients, advocates and researchers talk science, health disparities and filling in crucial data gaps at 'mets' conference
Sept. 26, 2017
| By Diane Mapes / Fred Hutch News Service
More than 300 metastatic breast cancer patients, researchers, advocates and caregivers gathered in Seattle over the weekend to discuss promising new therapies, patient-researcher partnerships, big data, advocacy, and, yes, cures.
Clinical trial in Uganda will test alternative diagnostic tool and oral chemotherapy, study genetic differences
Aug. 15, 2017
| By Mary Engel / Fred Hutch News Service
Researchers from Fred Hutchinson Cancer Research Center and the Uganda Cancer Institute are launching a clinical study in the Ugandan capital Kampala that could change the way breast cancer in sub-Saharan Africa is diagnosed and treated.
‘Functional genomics’ method aims to marry three powerful techniques to speed personalized cancer treatments to patients
March 31, 2017
| By Rachel Tompa / Fred Hutch News Service
Dr. Christopher Kemp is confident that the answer to personalized cancer treatment is written in the molecules inside each patient’s tumor, we just need to figure out how to separate the wheat from the chaff.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.